CN113846087A - 一种样品前处理方法及其应用 - Google Patents
一种样品前处理方法及其应用 Download PDFInfo
- Publication number
- CN113846087A CN113846087A CN202111112653.5A CN202111112653A CN113846087A CN 113846087 A CN113846087 A CN 113846087A CN 202111112653 A CN202111112653 A CN 202111112653A CN 113846087 A CN113846087 A CN 113846087A
- Authority
- CN
- China
- Prior art keywords
- sample
- coronavirus
- detection
- external force
- biomolecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002203 pretreatment Methods 0.000 title abstract description 8
- 238000001514 detection method Methods 0.000 claims abstract description 59
- 239000003761 preservation solution Substances 0.000 claims abstract description 15
- 230000009870 specific binding Effects 0.000 claims abstract description 5
- 230000009871 nonspecific binding Effects 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 47
- 241000711573 Coronaviridae Species 0.000 claims description 29
- 102000036639 antigens Human genes 0.000 claims description 15
- 108091007433 antigens Proteins 0.000 claims description 15
- 238000002604 ultrasonography Methods 0.000 claims description 15
- 239000000427 antigen Substances 0.000 claims description 11
- 241000700605 Viruses Species 0.000 claims description 8
- 230000002779 inactivation Effects 0.000 claims description 8
- 210000003296 saliva Anatomy 0.000 claims description 6
- 208000001528 Coronaviridae Infections Diseases 0.000 claims description 4
- 208000025370 Middle East respiratory syndrome Diseases 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 241000712461 unidentified influenza virus Species 0.000 claims description 4
- 241000710777 Classical swine fever virus Species 0.000 claims description 3
- 241000710198 Foot-and-mouth disease virus Species 0.000 claims description 3
- 108090001074 Nucleocapsid Proteins Proteins 0.000 claims description 3
- 229940096437 Protein S Drugs 0.000 claims description 3
- 102000029301 Protein S Human genes 0.000 claims description 3
- 101710198474 Spike protein Proteins 0.000 claims description 3
- 108700010904 coronavirus proteins Proteins 0.000 claims description 3
- 230000005684 electric field Effects 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 241000186361 Actinobacteria <class> Species 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- 241000606161 Chlamydia Species 0.000 claims description 2
- 241000709661 Enterovirus Species 0.000 claims description 2
- 101800001632 Envelope protein E Proteins 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- 241001428935 Human coronavirus OC43 Species 0.000 claims description 2
- 108010052285 Membrane Proteins Proteins 0.000 claims description 2
- 102000018697 Membrane Proteins Human genes 0.000 claims description 2
- 241000204031 Mycoplasma Species 0.000 claims description 2
- 206010036790 Productive cough Diseases 0.000 claims description 2
- 241000606701 Rickettsia Species 0.000 claims description 2
- 241000315672 SARS coronavirus Species 0.000 claims description 2
- 241000589970 Spirochaetales Species 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000001124 body fluid Anatomy 0.000 claims description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 108010028403 hemagglutinin esterase Proteins 0.000 claims description 2
- 239000002689 soil Substances 0.000 claims description 2
- 210000003802 sputum Anatomy 0.000 claims description 2
- 208000024794 sputum Diseases 0.000 claims description 2
- 210000004243 sweat Anatomy 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 238000007781 pre-processing Methods 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 15
- 239000012535 impurity Substances 0.000 abstract description 9
- 238000001179 sorption measurement Methods 0.000 abstract description 6
- 239000000523 sample Substances 0.000 description 40
- 239000011324 bead Substances 0.000 description 14
- 238000004140 cleaning Methods 0.000 description 8
- 241001112090 Pseudovirus Species 0.000 description 7
- 102100031673 Corneodesmosin Human genes 0.000 description 6
- 101710139375 Corneodesmosin Proteins 0.000 description 6
- 238000003018 immunoassay Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000004907 flux Effects 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000009210 therapy by ultrasound Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 101710141454 Nucleoprotein Proteins 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000007847 digital PCR Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241001529459 Enterovirus A71 Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000009022 nonlinear effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
每100μL假病毒数 | 一组 | 二组 | 三组 | 平均 |
0 | 0.27% | 0.16% | 0.22% | 0.22% |
2 | 0.50% | 0.43% | 0.44% | 0.45% |
5 | 0.86% | 0.92% | 1.05% | 0.94% |
20 | 4.94% | 4.12% | 3.33% | 4.13% |
100 | 24.47% | 19.71% | 16.40% | 20.19% |
200 | 35.74% | 45.36% | 36.09% | 39.06% |
样本编号 | 未经超声处理 | 经超声处理 |
1 | 0.50% | 0.17% |
2 | 4.28% | 0.49% |
3 | 2.24% | 0.34% |
4 | 2.87% | 0.17% |
5 | 12.2% | 2.51% |
6 | 2.34% | 0.17% |
平均 | 4.07% | 0.64% |
一组 | 二组 | 平均 | |
未经超声处理 | 0.27% | 0.22% | 0.25% |
60W超声5min | 0.06% | 0.14% | 0.10% |
60W超声15min | 0.08% | 0.05% | 0.07% |
60W超声30min | 0.06% | 0.06% | 0.06% |
90W超声5min | 0.09% | 0.17% | 0.13% |
90W超声15min | 0.05% | 0.04% | 0.05% |
90W超声30min | 0.07% | 0.05% | 0.06% |
150W超声5min | 0.10% | 0.10% | 0.10% |
150W超声15min | 0.07% | 0.04% | 0.06% |
150W超声30min | 0.08% | 0.05% | 0.07% |
Claims (15)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2020110231686 | 2020-09-25 | ||
CN202011023168 | 2020-09-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113846087A true CN113846087A (zh) | 2021-12-28 |
Family
ID=78979191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111112653.5A Pending CN113846087A (zh) | 2020-09-25 | 2021-09-23 | 一种样品前处理方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113846087A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2069002C1 (ru) * | 1992-07-14 | 1996-11-10 | Владимир Николаевич Благодатный | Способ выявления вирусного антигена в фекалиях |
CN108088935A (zh) * | 2017-12-07 | 2018-05-29 | 广西质量技术工程学校 | 一种检测水产品中氯霉素残留的样品前处理方法 |
CN111172239A (zh) * | 2020-02-28 | 2020-05-19 | 上海思路迪医学检验所有限公司 | 一种病毒样本保存液、核酸提取试剂及病毒核酸提取方法 |
CN111471803A (zh) * | 2020-05-29 | 2020-07-31 | 武汉生命之美科技有限公司 | 一种新型冠状病毒covid-19感染检测试剂盒 |
-
2021
- 2021-09-23 CN CN202111112653.5A patent/CN113846087A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2069002C1 (ru) * | 1992-07-14 | 1996-11-10 | Владимир Николаевич Благодатный | Способ выявления вирусного антигена в фекалиях |
CN108088935A (zh) * | 2017-12-07 | 2018-05-29 | 广西质量技术工程学校 | 一种检测水产品中氯霉素残留的样品前处理方法 |
CN111172239A (zh) * | 2020-02-28 | 2020-05-19 | 上海思路迪医学检验所有限公司 | 一种病毒样本保存液、核酸提取试剂及病毒核酸提取方法 |
CN111471803A (zh) * | 2020-05-29 | 2020-07-31 | 武汉生命之美科技有限公司 | 一种新型冠状病毒covid-19感染检测试剂盒 |
Non-Patent Citations (3)
Title |
---|
"新型冠状病毒感染的肺炎诊疗方案(试行第五版)", no. 03, pages 1 - 3 * |
刘育京: "《中国医学百科全书:消毒、杀虫灭鼠》", vol. 1988, 上海科学技术出版社, pages: 9 * |
张友春;汪睿;朱永良;: "新型冠状病毒实验室检测方法研究进展", no. 04, pages 361 - 365 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhou et al. | Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin | |
Bchetnia et al. | The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status | |
Di Teodoro et al. | SARS-CoV-2 replicates in respiratory ex vivo organ cultures of domestic ruminant species | |
Ozma et al. | Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period | |
Albariño et al. | Novel paramyxovirus associated with severe acute febrile disease, South Sudan and Uganda, 2012 | |
Smith et al. | Isolation and assay of rabies serogroup viruses in CER cells | |
Rudd et al. | Development and evaluation of an in vitro virus isolation procedure as a replacement for the mouse inoculation test in rabies diagnosis | |
US20110027774A1 (en) | Highly sensitive method for detection of viral hiv dna remaining after antiretroviral therapy of aids patients | |
CN110101705A (zh) | Bet家族蛋白抑制剂的抗病毒用途 | |
Öhrmalm et al. | Flocked nasal swab versus nasopharyngeal aspirate for detection of respiratory tract viruses in immunocompromised adults: a matched comparative study | |
Banach et al. | Human airway epithelial cell culture to identify new respiratory viruses: coronavirus NL63 as a model | |
Dong et al. | Studies on the pathogenesis of a Chinese strain of bovine parainfluenza virus type 3 infection in Balb/c mice | |
Guo et al. | Identification and genomic characterization of a novel porcine parvovirus in China | |
CN113846087A (zh) | 一种样品前处理方法及其应用 | |
Ai et al. | Genomic characteristics and pathogenicity of a new bat adenoviruses strains that was isolated in at sites along the southeastern coasts of the PR of China from 2015 to 2019 | |
Afzal et al. | Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigations | |
Caruso et al. | Evaluation of viral inactivation of pseudorabies virus, encephalomyocarditis virus, bovine viral diarrhea virus and porcine parvovirus in pancreatin of porcine origin | |
CN113736913B (zh) | 基于病毒核酸与miRNA双向共生检测2019-nCoV的方法及试剂盒 | |
CN103131797B (zh) | 一种博卡病毒实时荧光pcr检测试剂盒及其应用 | |
WO2022025029A1 (ja) | in vitroにおいてコロナウイルス科に属するウイルスを増殖させる方法、コロナウイルス科に属するウイルスに対する中和抗体の産生方法、及びSevere acute respiratory syndrome coronavirus 2の感染モデルの製造方法 | |
Siddell et al. | Coronaviruses | |
CN1468955A (zh) | 一种新型冠状病毒 | |
Hu et al. | Harringtonine has the effects of double blocking SARS-CoV-2 membrane fusion | |
Madanayake et al. | Electron microscopic methods for virus diagnosis | |
Andriushkova et al. | The role of the persistent enterovirus infection in development of acute stroke |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230602 Address after: 510130 No.6, helix 3 Road, Guangzhou International Biological Island, Haizhu District, Guangzhou City, Guangdong Province Applicant after: Bioisland Laboratory Applicant after: Institute of Biophysics, Chinese Academy of Sciences Applicant after: Guangzhou National Laboratory Address before: 510130 No.6, helix 3 Road, Guangzhou International Biological Island, Haizhu District, Guangzhou City, Guangdong Province Applicant before: Bioisland Laboratory Applicant before: Institute of Biophysics, Chinese Academy of Sciences |
|
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211228 |